Pediatric Continuous Renal Replacement Therapy (PCRRT) expert committee recommendation on prescribing prolonged

Sidharth Kumar Sethi1, Aliza Mittal2, Nikhil Nair3

  • 1Pediatric Nephrology, Medanta, The Medicity, Gurgaon, India.

Hemodialysis International. International Symposium on Home Hemodialysis
|February 20, 2020
PubMed

Insights

Prolonged intermittent renal replacement therapies (PIRRT) offer a cost-effective option for pediatric intensive care. This study provides initial guidelines for PIRRT use in children, addressing its definition, indications, and prescription.

Area of Science:

  • Pediatric Nephrology
  • Critical Care Medicine
  • Renal Replacement Therapy

Background:

  • Prolonged intermittent renal replacement therapies (PIRRT) are increasingly utilized as a cost-effective alternative to continuous therapies in pediatric intensive care.
  • Despite growing use, a consensus on PIRRT guidelines for pediatric patients remains absent.

Purpose of the Study:

  • To develop evidence-based recommendations for the application of PIRRT in pediatric intensive care settings.
  • To establish guidelines for the definition, indications, machine selection, and prescription of PIRRT in children.

Main Methods:

  • A comprehensive literature search was conducted across PubMed/Medline, Embase, and Google Scholar.
  • Medical librarians from India and Cleveland Clinic assisted in identifying relevant studies.
  • The Pediatric Continuous Renal Replacement Therapy workgroup analyzed articles for relevance and graded evidence strength.

Main Results:

  • Sixty studies were initially identified, with data from 37 studies used to formulate the guidelines.
  • The developed guidelines cover key aspects of PIRRT, including its definition, indications, associated machinery, and prescription protocols.
  • Recommendations were graded based on the strength of evidence.

Conclusions:

  • The literature on PIRRT in pediatric populations is currently limited.
  • Existing studies support the benefits of PIRRT in children.
  • These expert recommendations represent a crucial initial step towards further research and standardized practice of PIRRT in pediatric critical care.
Abstract

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
628
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
121
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
228
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
281
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
172